Rheumatology Network's Top 5: September 17, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending September 17, 2021.
Perceived Risk of COVID-19 Infection in Patients With Rheumatoid Arthritis
“The COVID-19 pandemic has strongly impacted the lives of patients living with rheumatoid arthritis which has contributed to anxiety, depression, and reduced well-being.”
Click the image to view the story.
Long-Term Golimumab Treatment in Patients With Psoriatic Arthritis
The efficacy evaluation of golimumab is crucial for patients with psoriatic arthritis, particularly for treating skin manifestations and psoriasis symptoms.
Click the image to view the story.
The Relationship Between Unhealthy Lifestyle Factors and Rheumatoid Arthritis
While lifestyle habits are modifiable risk factors, changing them can be especially challenging for patients with rheumatoid arthritis, who must also deal with chronic inflammatory disease.
Click the image to view the story.
Single Serum Urate Measurements Deemed Unreliable for Identifying Hyperuricemia
Hyperuricemia is associated with vascular, cardiac, and renal disease, as well as gout. However, the reliability of a single measurement in defining hyperuricemia is unclear.
Click the image to view the story.
Favorable COVID-19 Outcomes in Pregnant Women With Rheumatic Disease
COVID-19 has added an additional level of complexity for patients with rheumatic disease who wish to become pregnant.
Click the image to view the story.
